Monensin

Overview

Monensin (Monensin A), an orally active antibiotic , is an ionophore that mediates Na + /H + exchange . Monensin is a potent Wnt signaling inhibitor. Monensin causes a marked enlargement of the multivesicular bodies (MVBs) and regulates exosome secretion. Monensin can be used for bacterial , fungal , and parasitic infections research, and shows anticancer effects.

Application

Products | Products > Disease Areas > Cancer | Products > Disease Areas > Infection | Products > Signaling Pathways > Cytoskeleton | Products > Signaling Pathways > Anti-infection | Products > Signaling Pathways > Apoptosis | Products > Signaling Pathways > Membrane Transporter/Ion Channel | Products > Signaling Pathways > Stem Cell/Wnt | Products > Research Areas > Infection | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Immunotherapy | Products > Research Areas > Cancer > Cancer Stem Cells | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Signaling Pathways > Antibiotic | Products > Signaling Pathways > Parasite | Products > Signaling Pathways > Na+/H+ Exchanger (NHE) | Products > Signaling Pathways > Fungal | Products > Signaling Pathways > Wnt | Products > Signaling Pathways > Exosomes | Products > Signaling Pathways > Bacterial | Products > Signaling Pathways > Apoptosis

Product Information

• Catalog No.: HY-N4302
• CAS No.: 17090-79-8
• Molecular Formula: C36H62O11
• Molecular Weight: 670.87
• Purity: 98.07%
• Storage: Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 6 months , -20°C, 1 month
• Solubility: ≥ 2.5 mg/mL (3.73 mM); Clear solution
• Availability: In-stock

Source

Original product source